Today: 19 May 2026
Browse Category

NYSE:HCA 1 November 2025 - 24 April 2026

HCA Healthcare Stock Drops Despite Profit Beat As Weak Volumes Rattle Investors

HCA Healthcare Stock Drops Despite Profit Beat As Weak Volumes Rattle Investors

HCA Healthcare shares dropped 8.8% to $432.46 after first-quarter profit narrowly beat estimates but showed weaker patient volumes and payer-mix concerns. Revenue rose 4.3% to $19.1 billion, net income hit $1.62 billion, and adjusted EBITDA climbed 1.9% to $3.8 billion. Respiratory admissions fell 42% year-over-year. HCA reaffirmed its 2026 financial guidance.
24 April 2026
····
HCA Healthcare stock stays firm after-hours after a sharp run — here’s what traders watch next

HCA Healthcare stock stays firm after-hours after a sharp run — here’s what traders watch next

HCA Healthcare shares rose 0.7% to $535.22 in after-hours trading Thursday after hitting a high of $552.85 earlier in the day. The move follows a 5.86% jump Wednesday to a record close after HCA’s 2026 profit outlook topped estimates and the company announced a $10 billion buyback. A shareholder filed to sell 8,020 shares worth about $4.1 million. Investors await Friday’s U.S. CPI report.
12 February 2026
···
HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare stock slides as traders digest $10B buyback, 2026 outlook and ACA headwinds

HCA Healthcare shares fell 2.8% to $491.72 Wednesday, erasing some of Tuesday’s 11% rally after earnings. The company set 2026 EPS guidance at $29.10–$31.50 and announced a $10 billion share buyback. Investors weighed cost cuts against risks from changes in ACA coverage and payer mix. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income up 30.6% to $1.88 billion.
28 January 2026
·
HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA Healthcare shares surged 7.1% to $505.84 after the company raised its 2026 profit outlook and approved a new $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income at $1.88 billion. Investors remain cautious as ACA exchange subsidies expire, potentially reducing patient volumes. The board also declared a $0.78 quarterly dividend, payable March 31.
28 January 2026
··
HCA Healthcare stock jumps on upbeat 2026 outlook, $10B buyback as ACA subsidy cliff looms

HCA Healthcare stock jumps on upbeat 2026 outlook, $10B buyback as ACA subsidy cliff looms

HCA Healthcare shares jumped 7.4% to $507.50 Tuesday after the company raised its 2026 profit outlook and announced a $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with adjusted earnings at $8.01 per share. HCA expects 2026 revenue between $76.5 billion and $80 billion, and earnings per share of $29.10 to $31.50. The board approved a quarterly dividend of $0.78 per share, payable March 31.
27 January 2026
·
HCA Healthcare (HCA) Stock After Hours on Dec. 24, 2025: What Happened After the Bell and What to Know Before Markets Reopen

HCA Healthcare (HCA) Stock After Hours on Dec. 24, 2025: What Happened After the Bell and What to Know Before Markets Reopen

HCA Healthcare closed at $474.06 in a shortened Christmas Eve session, then slipped to $468.74 in after-hours trading, down 1.12%. Trading volume was about 250,000 shares, well below normal. U.S. stock markets will remain closed for Christmas Day and reopen Friday, Dec. 26, 2025. Policy uncertainty over ACA premium subsidies continues to weigh on the healthcare sector.
25 December 2025
·
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Healthcare shares closed at $484.77 on Friday, ending the week nearly unchanged after a sharp 4% drop Wednesday on heavy volume. The midweek decline followed reports of possible Medicare reimbursement cuts under discussion in Congress. HCA remains below its late-November record high of $515.85. Trading volatility this week drew renewed focus to policy risk for hospital operators.
13 December 2025
·
HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare stock closed near $503 on December 2, 2025, up over 38% from its July peak, following record Q3 results and raised guidance. Q3 revenue rose 9.6% to $19.2 billion, with net income up 29% to $1.64 billion. The company repurchased 6.5 million shares in Q3 and maintained a quarterly dividend of $0.72 per share. Market cap stands around $117 billion.
3 December 2025
··
HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

HCA Healthcare closed at about $503 on December 1, down 1% from Friday and just below its record high of $520 set in the prior session. Institutional investors shifted positions, with Dixon Mitchell raising its stake by 6.9% and others reducing holdings. The stock is up 71.5% year-to-date and trades at a discount to sector averages. Institutional holders control about 62.7% of shares.
1 December 2025
·
Tech Turmoil: iPhone 17 Stuns, Starlink Outage, Cyber Hacks & Chip Wars – Non-AI News Roundup (Sept 14–15, 2025)

AI Frenzy Unleashed: Nvidia Rockets to $5T, Google’s Gemini Enterprise Debuts, and Global AI Battles Heat Up

Nvidia became the world’s first $5 trillion company as demand for its AI chips soared. Microsoft and OpenAI reset their partnership, with OpenAI set to buy $250 billion more in Azure services and Microsoft dropping its right of first refusal. Google launched Gemini Enterprise for business AI, while Meta and Alphabet sharply increased AI spending. Intel is in talks to acquire SambaNova, and the US Energy Department partnered with AMD to build two new AI supercomputers.
1 November 2025
········

Stock Market Today

  • 8x8 Beats Q1 Sales Estimates, Shares Surge 15%
    May 19, 2026, 5:24 PM EDT. Cloud communications firm 8x8 (NASDAQ:EGHT) reported Q1 CY2026 revenue of $185.2 million, 4.6% higher year-on-year and surpassing analysts' $181.1 million estimate. Adjusted earnings per share stood at $0.11, beating the consensus by 41.9%. The company forecasted Q2 revenue of $182.5 million, aligning with market expectations. Operating margin expanded to 1.8% from 0.2% last year, while free cash flow margin declined to 6.1%. CEO Samuel Wilson highlighted four consecutive quarters of revenue growth and the first GAAP profit since 2015. Despite short-term strength, 8x8's long-term revenue growth remains modest, with analysts projecting flat sales over the next year. Market cap reached $333 million following a 15% stock rise.

Latest articles

SMCI Stock Alert: Super Micro Slips as Sales Shake-Up Tests AI Server Rally

SMCI Stock Alert: Super Micro Slips as Sales Shake-Up Tests AI Server Rally

19 May 2026
Super Micro Computer shares fell 0.9% to $30.56 Tuesday after a filing showed longtime sales chief Don Clegg retired, effective May 15. The company named Matthew Thauberger as chief revenue officer last week. Super Micro reported third-quarter net sales of $10.2 billion, up from $4.6 billion a year earlier, but missed Wall Street revenue estimates.
Keysight Shares Surge as Orders Hit Record High

Keysight Shares Surge as Orders Hit Record High

19 May 2026
Keysight Technologies shares climbed nearly 4% in after-hours trading Tuesday after reporting fiscal Q2 revenue of $1.72 billion and adjusted earnings of $2.87 per share, beating analyst estimates. Orders rose to $2.05 billion from $1.32 billion a year earlier. The stock closed at $344.11, then traded at $357.80 after the bell. S&P 500 and Nasdaq both fell during the session.
AMD Stock Just Slipped Before Nvidia’s Big Test — Here’s What Changed

AMD Stock Just Slipped Before Nvidia’s Big Test — Here’s What Changed

19 May 2026
AMD shares fell 1.6% to $414.05 Tuesday after a volatile session, as investors trimmed chip stock holdings ahead of Nvidia’s earnings and rising Treasury yields pressured tech names. Citi raised its AMD price target to $460 but maintained a Neutral rating. Nvidia, down 0.7%, will report results Wednesday, with options implying a $355 billion market value swing. Intel rose 2.4%.
Go toTop